Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Severe Myoclonic Epilepsy of Infancy”

84 trials

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 84 results

Not applicableActive Not RecruitingNCT05472389
What this trial is testing

Neurodevelopmental Impact of Epilepsy on Autonomic Function in Dravet Syndrome

Who this might be right for
Dravet SyndromeEpilepsy
Hospices Civils de Lyon 92
Not applicableWithdrawnNCT05140122
What this trial is testing

LEONIDaS Caregivers Study

Who this might be right for
Dravet SyndromeDepressionAnxiety
University of Oxford
Not applicableApproved For MarketingNCT04437004
What this trial is testing

Treatment of Dravet Syndrome With Fenfluramine (Expanded Access Protocol)

Who this might be right for
Dravet Syndrome
University of California, Los Angeles
Early research (Phase 1)Study completedNCT02286986
What this trial is testing

Cannabidiol (CBD) to 27 Patients (Aged 2 Years - 19 Years) With Drug Resistant Epilepsy

Who this might be right for
Epilepsy
University of Utah 26
Not applicableApproved For MarketingNCT03780127
What this trial is testing

ZX008 Expanded Access Protocol

Who this might be right for
Dravet Syndrome
Zogenix, Inc.
Not applicableStudy completedNCT03857451
What this trial is testing

Treatment of Gait Disorders in Children With Dravet Syndrome

Who this might be right for
Dravet SyndromeSevere Myoclonic Epilepsy of Infancy
Universiteit Antwerpen 50
Testing effectiveness (Phase 2)Active Not RecruitingNCT04740476
What this trial is testing

An Open-Label Extension Study of STK-001 for Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Stoke Therapeutics, Inc 60
Not applicableNo Longer AvailableNCT02239276
What this trial is testing

Expanded Access Use of Stiripentol in Dravet Syndrome or Sodium Channel Mutation Epileptic Encephalopathies

Who this might be right for
Dravet SyndromeEpileptic Encephalopathies Associated With SCN1A Mutations
Cook Children's Health Care System
Not applicableUnknownNCT06504511
What this trial is testing

SCN1A Horizons A Natural History Study of SCN1A-related Epilepsies in the United Kingdom

Who this might be right for
SCN1ADravet SyndromeEpilepsy
NHS Greater Glasgow and Clyde 400
Not applicableEnded earlyNCT04537832
What this trial is testing

Natural History Study of Infants and Children With Developmental and Epileptic Encephalopathies

Who this might be right for
Dravet Syndrome
Encoded Therapeutics 58
Not applicableStudy completedNCT07592650
What this trial is testing

Applicability and Effectiveness of Remote Occupational Therapy

Who this might be right for
Dravet Syndrome
Fondazione Policlinico Universitario Agostino Gemelli IRCCS 14
Large-scale testing (Phase 3)Study completedNCT02224703
What this trial is testing

GWPCARE2 A Study to Investigate the Efficacy and Safety of Cannabidiol (GWP42003-P) in Children and Young Adults With Dravet Syndrome

Who this might be right for
EpilepsyDravet Syndrome
Jazz Pharmaceuticals 199
Not applicableApproved For MarketingNCT01983722
What this trial is testing

Treatment Plan to Provide Expanded Access to Stiripentol for Patients With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Children's Hospital Medical Center, Cincinnati
Large-scale testing (Phase 3)Ended earlyNCT03299842
What this trial is testing

Assess the Usability of the Embrace Seizure Detection Watch in Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Zogenix International Limited, Inc., a subsidiary of Zogenix, Inc. 5
Testing effectiveness (Phase 2)Study completedNCT01607073
What this trial is testing

Verapamil as Therapy for Children and Young Adults With Dravet Syndrome

Who this might be right for
Dravet Syndrome
Gillette Children's Specialty Healthcare 2
Early research (Phase 1)Study completedNCT07176832
What this trial is testing

Bioavailability of Stiripentol After Single Oral Dose of Capsule vs Suspension in Healthy Subjects (STILIQ)

Who this might be right for
Dravet SyndromeEpilepsyChildhood+2 more
Biocodex 24
Testing effectiveness (Phase 2)Study completedNCT02758626
What this trial is testing

Ataluren for Nonsense Mutation in CDKL5 and Dravet Syndrome

Who this might be right for
Epilepsy
NYU Langone Health 15
Large-scale testing (Phase 3)Ended earlyNCT06422377
What this trial is testing

A Study Evaluating Soticlestat in Participants With Dravet Syndrome or Lennox-Gastaut Syndrome Who Have Been Exposed to Fenfluramine

Who this might be right for
Dravet Syndrome (DS)Lennox-Gastaut Syndrome (LGS)
Takeda 1
Large-scale testing (Phase 3)Ended earlyNCT05560282
What this trial is testing

Fenfluramine for Adult Dravet Patients

Who this might be right for
Dravet SyndromeDravet Syndrome, Intractable
University Health Network, Toronto 7
Testing effectiveness (Phase 2)Looking for participantsNCT07531745
What this trial is testing

ASCEND: Safety and Tolerability of ION337 for the Treatment of Dravet Syndrome

Who this might be right for
Dravet Syndrome
Ionis Pharmaceuticals, Inc. 32
Next Page